Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification
Inge Van Der Werf
, Anna Wojtuszkiewicz
, Manja Meggendorfer
, Stephan Hutter
, Constance Baer
, Martijn Heymans
, Peter J.M. Valk
, Wolfgang Kern
, Claudia Haferlach
, Jeroen J.W.M. Janssen
, Gert J. Ossenkoppele
, Jacqueline Cloos
, Torsten Haferlach
Research output: Contribution to journal › Article › peer-review
42Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification'. Together they form a unique fingerprint.
Keyphrases
Biochemistry, Genetics and Molecular Biology
Pharmacology, Toxicology and Pharmaceutical Science